Patrick Petrossians Selected Research

2,2',3',4,4',5-hexachlorobiphenyl

1/2020

Association between mixture of persistent organic pollutants and thyroid pathologies in a Belgian population.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Patrick Petrossians Research Topics

Disease

13	Acromegaly 01/2022 - 01/2005
12	Neoplasms (Cancer) 01/2022 - 01/2005
8	Pituitary Neoplasms (Pituitary Adenoma) 01/2022 - 01/2005
7	Prolactinoma (Prolactinomas) 04/2019 - 11/2010
6	Adenoma (Adenomas) 06/2020 - 01/2005
2	Hypothyroidism 03/2022 - 01/2020
2	Cushing Syndrome 01/2022 - 01/2010
2	Gigantism 01/2022 - 12/2018
2	Disease Progression 12/2019 - 02/2016
2	Hyperprolactinemia 01/2017 - 01/2017
2	Neuroendocrine Tumors (Neuroendocrine Tumor) 01/2010 - 11/2009
1	Goiter 03/2022
1	Hyperthyroidism 01/2020
1	Type 2 Diabetes Mellitus (MODY) 01/2020
1	Carcinogenesis 12/2019
1	Paraganglioma (Paragangliomas) 12/2019
1	Multiple Endocrine Neoplasia (Multiple Endocrine Adenomatosis) 12/2019
1	Familial Isolated Pituitary Adenoma 04/2019
1	Endocrine System Diseases (Endocrine Diseases) 01/2017
1	Parkinson Disease (Parkinson's Disease) 01/2017
1	Hyperplasia 06/2015
1	Polyostotic Fibrous Dysplasia (McCune Albright Syndrome) 10/2014
1	Hypertension (High Blood Pressure) 06/2011
1	Genetic Predisposition to Disease (Genetic Predisposition) 03/2011
1	Pituitary ACTH Hypersecretion 01/2010
1	Growth Hormone-Secreting Pituitary Adenoma 01/2005

Drug/Important Bio-Agent (IBA)

6	Insulin-Like Growth Factor I (IGF-1)IBA 01/2022 - 11/2009
6	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 06/2020 - 01/2005
5	ProlactinIBA 02/2016 - 06/2011
4	Growth Hormone (Somatotropin)IBA 01/2022 - 11/2009
4	Cabergoline FDA LinkGeneric 01/2017 - 01/2010
3	Dopamine Agonists (Dopamine Agonist)IBA 01/2017 - 01/2010
2	Adrenocorticotropic Hormone (ACTH)FDA Link 01/2022 - 01/2010
2	LigandsIBA 01/2022 - 01/2020
2	pegvisomant FDA LinkGeneric 06/2020 - 11/2009
2	pasireotideIBA 06/2020 - 01/2019
2	Somatostatin Receptors (Somatostatin Receptor)IBA 01/2020 - 06/2015
2	aryl hydrocarbon receptor-interacting proteinIBA 12/2019 - 10/2011
2	Insulin-Like PeptidesIBA 12/2018 - 06/2012
2	Hormones (Hormone)IBA 11/2016 - 11/2009
1	Thyroid HormonesIBA 03/2022
1	TabletsIBA 03/2022
1	lanreotide (Somatuline)FDA Link 12/2021
1	Insulin (Novolin)FDA Link 01/2020
1	2,2',3',4,4',5-hexachlorobiphenylIBA 01/2020
1	Flame Retardants (Fire Retardants)IBA 01/2020
1	Polychlorinated Biphenyls (PCBs)IBA 01/2020
1	Cyclin-Dependent Kinase Inhibitor p27IBA 12/2019
1	Myc associated factor XIBA 12/2019
1	Succinate Dehydrogenase (Fumarate Reductase)IBA 12/2019
1	Ubiquitin-Specific ProteasesIBA 12/2019
1	Biological ProductsIBA 04/2015
1	GTP-Binding Proteins (G-Protein)IBA 10/2014
1	DNA (Deoxyribonucleic Acid)IBA 03/2011
1	Transcription Factors (Transcription Factor)IBA 11/2009

Therapy/Procedure

7	Therapeutics 06/2020 - 01/2005
2	Radiotherapy 11/2010 - 11/2009